Corium
International, Inc. is a commercial-stage biopharmaceutical company. It
is focused on the development, manufacture and commercialization of
specialty pharmaceutical products that leverage advanced technologies in
transdermal and transmucosal delivery systems. Corium has developed six
marketed products in the prescription drug and consumer markets:
Clonidine Transdermal Delivery System for hypertension, Fentanyl TDS for
chronic pain and four Crest Advanced Seal Whitestrips products. The
company has two proprietary transdermal technology platforms with
applications in multiple drug categories and indications: Corplex(TM)
and MicroCor(R). Corium International, Inc. is headquartered in Menlo
Park, California. technical indicators:
Fundamental factors:
The most reliable technical trading strategy for this stock has been the price vs the 100 day moving average.
|
Tuesday, May 26, 2015
Chart of the Day - Corium International (CORI)
The Chart of the Day belongs to Corium International (CORI). I found the stock by sorting today's All Time High list
for the stocks with the highest technical buy signals, then used the
Flipchart feature to review the charts. Since the Trend Spotter
signaled a buy on 4/29 the stock gained 42.7%.
Please share this article
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment